Anthropic accelerates drug development with AI
The story so far
Anthropic partnered with six pharmaceutical companies to use Claude Code for drug development tasks, including designing shorter gene instructions for CAR T-cell therapy (the standard version is 70% longer, the new design increases the generation of immune cell receptors by about 10 times), generating approximately 35,000 antibody designs for food allergy treatment (20 designs are better than standard drugs), and optimizing the binding affinity, stability, and anti-aggregation properties of two antibody fragment drug molecules (binding force improved after improvement).
AI-written from the reports · Updated 22 days ago
Coverage timeline
Follow the coverage to see every side of the story.
- Anthropic ResearchEarly progress on accelerating drug development with Claude
Anthropic collaborates with six pharmaceutical companies to use Claude Code for drug development tasks, including designing shorter gene instructions for CAR T cell therapy (standard version 70% longer, new design increases immune cell receptor generation by about 10 times), generating approximately 35,000 antibody designs for food allergy treatment (20 designs are better than standard drugs), and optimizing the binding affinity, stability, and anti-aggregation properties of two antibody fragment drug molecules (binding force improved after improvement).